
INACTIVE/DISSOLVED
Founded
31 Dec 2005
Address
Tragara Pharmaceuticals Inc
10955 Vista Sorrento Parkway
Suite 120
San Diego, CA 92130
United States
Tragara Pharmaceuticals Inc
3152 Lionshead Avenue
Carlsbad, CA 92010
United States
Tragara Pharmaceuticals Inc
3152 Lionshead Avenue
Carlsbad, CA 92010
United States
Tragara Pharmaceuticals Inc
3152 Lionshead Avenue
Carlsbad, CA 92010
United States
Tragara Pharmaceuticals Inc
3152 Lionshead Avenue
Carlsbad, CA 92010
United States
Phone
Website
VCID: 345009
Profile
Corporate information
Registration country
Registration country
Investment activity status
Not investing
Company type
Development of proprietary drugs for the treatment of cancer and inflammation-related disorders.Funding
Funding rounds
Investor | Profile | Country | Notes | |
---|---|---|---|---|
![]() |
Domain Associates LLC | Venture capital firm focused on life sciences companies. | United States |
Investor | Profile | Country | Notes | |
---|---|---|---|---|
![]() |
Morgenthaler Management Partners | One of the oldest private equity investment firms in the US investing through both venture capital and leverage buyout transactions. | United States |
Cap Table
Current and past shareholders
Investor | Contacts | Round | |
---|---|---|---|
![]() |
Domain Associates LLC Venture capital firm focused on life sciences companies. |
+1 (858) 480-2400 |
N/A |
![]() |
Mitsubishi Corp |
Series B | |
![]() |
Morgenthaler Management Partners One of the oldest private equity investment firms in the US investing through both venture capital and leverage buyout transactions. |
+1 (650) 388-7600 |
N/A |
![]() |
Oxford Bioscience Partners |
+1 (617) 357-7474 |
N/A |
![]() |
ProQuest Investments |
+1 (858) 847-0315 |
N/A |
Investments
Selected investments
Company | Country | Date | Notes | ||
---|---|---|---|---|---|
![]() |
S*Bio Pte Ltd Singapore-based cancer therapeutics company which, focuses on the discovery, research, and clinical development of small molecule drugs. |
Singapore | 21 Jan 2009 | Other USD 112,500,000 (USD 112,500,000) deal size. |